Pomegra
Zocdoc closed its first acquisition in nearly 20 years on October 2, 2026, buying insurance-eligibility startup Sohar Health to bring coverage checks in-house.
Key Takeaways
- Zocdoc acquired Sohar Health on October 2, 2026, and announced it October 14. It is the company's first acquisition.
- Price, structure and valuation were not disclosed. Sohar had raised $3.8M in seed funding.
- Sohar already powered insurance checks inside Zocdoc and supports 1,000+ U.S. payers.
Lead
Zocdoc, the New York appointment-booking marketplace founded by Oliver Kharraz, bought Sohar Health, a two-year-old startup that automates insurance eligibility and benefits checks. The deal closed October 2, 2026, and was announced October 14. Terms were not disclosed. The target is a small company whose technology Zocdoc was already using, which makes this a strategic purchase of a supplier, not an acquihire.
What Did Zocdoc Actually Buy?
Zocdoc bought an API-driven eligibility engine that tells a patient or provider, in seconds, whether a given insurance plan covers a visit and whether a provider is in network. Sohar Health was founded in 2023 by Ashish Mandavia, a physician, and Lucas Gordon, an engineer. It graduated from Y Combinator's Summer 2023 batch.
The company's product covers eligibility verification, benefits checks and network status across more than 1,000 U.S. payers. Its customers include BetterHelp, Headway, Rula and Talkiatry, all behavioral or digital health operators where front-end billing errors are costly. Mandavia and Gordon, the co-founders, are joining Zocdoc, according to the announcement.
Why Did Zocdoc Pay for Something It Already Used?
Zocdoc chose Sohar as its insurance verification partner in 2025 after evaluating legacy clearinghouses and newer eligibility APIs. Owning that layer removes a dependency on a vendor that sits in the middle of the booking flow. Insurance acceptance is the main filter patients apply when choosing a doctor, and a failed or slow check is a failed booking.
Zocdoc says millions of patients have already verified coverage through Sohar's technology inside its product. It lists more than 200,000 providers, 200-plus specialties and 10,000-plus insurance plans on its marketplace. A vendor that handles that volume is hard to swap out later, so buying it is the cheaper form of control.
The purchase also fits the company's push beyond its own website. Zocdoc launched a Care Access Network in October 2026 and counts Amazon Health AI, Gemini, Yelp, Healthgrades and Blue Shield of California among its partners. In that model, patients start a search on someone else's surface and Zocdoc supplies the bookable inventory. Eligibility checks have to run wherever the search starts, not only on Zocdoc's own pages.
What Does the Deal Say About Sohar's Last Round?
The acquisition follows a seed round of about $3.8M announced in March 2025, led by Kindred Capital, with Y Combinator, Concept Ventures, Rebel Fund and angels also participating. Some databases list the total as $4.0M. Neither Zocdoc nor Sohar disclosed a price, so whether investors made a return is unknown.
Eighteen months from seed to sale is quick. The usual path for a startup like this is a Series A on the strength of customer growth. Selling to its largest and best-known user suggests the founders preferred distribution through Zocdoc to a second raise in a field where verification vendors compete on price and uptime.
What Happens to Sohar's Other Customers?
Zocdoc has not said whether Sohar will keep selling to outside customers on the same terms. The announcement says Sohar's platform will be brought into Zocdoc, and Kharraz framed the goal as making insurance easier to navigate for patients and providers. Sohar's co-founders said joining Zocdoc lets them reach more patients.
Behavioral health networks such as BetterHelp and Talkiatry may now be buying a core billing input from a company that also operates a marketplace competing for the same patients. That is a conflict customers will weigh at renewal. The easiest reassurance for Zocdoc is to keep Sohar's API running as a separate product with its own commitments. The other path is to fold it into Zocdoc's own stack and let outside contracts lapse.
Strategic Context
Zocdoc has operated since 2007 without buying another company, so the deal breaks a long pattern. It also differs from the typical health tech acquisition, where a larger player buys revenue or headcount. Here the buyer is paying for a component it has already tested in production.
Industry pressure is the background. A KFF survey cited by Zocdoc found that about half of insured adults struggle to understand their coverage, and prior authorization and eligibility errors drive denied claims for providers. Any company that can answer "is this covered?" at the moment of booking holds a useful position.
Outlook
Zocdoc has bought a working piece of infrastructure from a seed-stage company at an undisclosed price, closing its first acquisition after nearly 20 years. The next signals are whether Sohar's outside customers stay and whether Zocdoc adds eligibility features to the Care Access Network partners. A second acquisition would show whether this was a one-off supplier purchase or the start of a buying program.
